Showing 161 - 180 results of 254 for search '"pathologists"', query time: 0.06s Refine Results
  1. 161

    Pathological and radiological assessment of benign breast lesions with BIRADS IVc/V subtypes. should we repeat the biopsy? by Wesam Rjoop, Anwar Rjoop, Alia Almohtaseb, Lama Bataineh, Zeina Nser Joubi, Maha Gharaibeh, Abdalrahman Al-Qwabah, Yousef Alasheh, Ismail Matalka

    Published 2025-02-01
    “…The study recommends a correlation between clinical and radiological findings and encourages multidisciplinary decision-making among radiologists, pathologists, and clinicians to determine if a repeat biopsy is warranted. …”
    Get full text
    Article
  2. 162

    An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with... by Xiaodan Zheng, Yuanyuan Zheng, Yanlin Zhang, Jianlan Xie, Xiaojing Teng, Kuo Bi, Lan Sun, Xiaowen Huang, Mulan Jin, Xiaoge Zhou

    Published 2025-01-01
    “…Abstract Background The differential diagnosis between adult systemic EBV-positive T-cell lymphoproliferative disorders (EBV+ T-LPD) and angioimmunoblastic T-cell lymphoma (AITL) with multiple EBV infections is difficult, and distinguishing between the two has become a diagnostic challenge for pathologists. Given that the clinical treatment plans are different, an accurate diagnosis is a prerequisite to ensure effective treatment, therefore, it is extremely necessary and meaningful to find effective pathological indicators for distinguishing between two diseases. …”
    Get full text
    Article
  3. 163

    Usefulness of Automatic Speech Recognition Assessment of Children With Speech Sound Disorders: Validation Study by Do Hyung Kim, Joo Won Jeong, Dayoung Kang, Taekyung Ahn, Yeonjung Hong, Younggon Im, Jaewon Kim, Min Jung Kim, Dae-Hyun Jang

    Published 2025-01-01
    “… BackgroundSpeech sound disorders (SSDs) are common communication challenges in children, typically assessed by speech-language pathologists (SLPs) using standardized tools. However, traditional evaluation methods are time-intensive and prone to variability, raising concerns about reliability. …”
    Get full text
    Article
  4. 164

    A Novel, Patient-Specific Mathematical Pathology Approach for Assessment of Surgical Volume: Application to Ductal Carcinoma in situ of The Breast by Mary E. Edgerton, Yao-Li Chuang, Paul Macklin, Wei Yang, Elaine L. Bearer, Vittorio Cristini

    Published 2011-01-01
    “…By obtaining these ratios at the time of initial biopsy, pathologists can employ our model to predict the size of the tumor and thereby inform surgeons how much tissue to remove (surgical volume). …”
    Get full text
    Article
  5. 165
  6. 166
  7. 167

    Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study by Samuel Smith, Peter Sasieni, William Cross, Richard Bryant, Steven Kennish, James Catto, Rachel Hubbard, Simon Faulkner, Rohit Chahal, Mohantha Dooldeniya, Marcus Cumberbatch, Bernard North, Alastair D Lamb, Roseann Kealy, Selina Bhattrai

    Published 2025-02-01
    “…An external panel of experts blinded to allocation will review all AS cessation and progression events. Trial pathologist’s and radiologist’s, blinded to allocation, will review representative cases. …”
    Get full text
    Article
  8. 168

    Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy by Zhifu Chen, Yan Wang, Jun Chen, Zijun Xu, Tingjuan Zhang, Lu Sun, Lihua Zhu, Liben Xu, Chaoyang Wu, Zhiyuan Qiu, Dianjun Wang, Ting Wu

    Published 2025-01-01
    “…Patients were grouped according to tumor regression grade (TRG) criteria from the College of American Pathologists (CAP). The correlation between TRG groups, clinicopathologic characteristics, and prognosis was analyzed. …”
    Get full text
    Article
  9. 169

    The Financial Implications of Pancreatic Surgery: The Hospital Is the Big Winner, Not the Surgeon! by Nitzan Zohar, MD, Avinoam Nevler, MD, Sean P. Maher, Matthew C. Rosenthal, Florence Williams, Wilbur B. Bowne, MD, FACS, Charles J. Yeo, MD, FACS, Harish Lavu, MD, FACS

    Published 2024-03-01
    “…The differences between the professional fee charges and receipts per patient were also considerable for other health care professionals such as anesthesiologists ($4945 charges vs $1406 receipts [28%]) and pathologists ($3035 charges vs $680 receipts [22%]). …”
    Get full text
    Article
  10. 170

    Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing by Ignacio I Wistuba, Michael T Tetzlaff, Carlo B Bifulco, Benjamin Green, Sacha Gnjatic, Scott J Rodig, Joel C Sunshine, Janis M Taube, Keith E Steele, Marlon C Rebelatto, David L Rimm, Ana Lako, Edwin R Parra, Guray Akturk, Michael Angelo, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Kurt A Schalper, Cláudia S Ferreira, Konstanty Korski, Emanuel Schenck, Michael J Surace, Jennifer H Yearley, Jeffrey S Roskes, Margaret Eminizer, Logan L Engle, Daniel Jiménez-Sánchez, Jamie Rodriguez-Canales, Alexander S Szalay

    Published 2025-01-01
    “…The current effort represents a complementary manuscript for mIHC/IF analysis focused on the associated image analysis and data management.Methods The Society for Immunotherapy of Cancer convened a task force of pathologists and laboratory leaders from academic centers as well as experts from pharmaceutical and diagnostic companies to develop best practice guidelines for the quantitative image analysis of mIHC/IF output and data management considerations.Results Best-practice approaches for image acquisition, color deconvolution and spectral unmixing, tissue and cell segmentation, phenotyping, and algorithm verification are reviewed. …”
    Get full text
    Article
  11. 171
  12. 172

    Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract by Mohammad Jad Moussa, Georges C. Tabet, Arlene O. Siefker‐Radtke, Lianchun Xiao, Nathaniel R. Wilson, Jianjun Gao, Christopher J. Logothetis, Petros Grivas, Byron Lee, Amishi Y. Shah, Pavlos Msaouel, Roger Li, Leticia Campos Clemente, Jianping Zhao, Nizar M. Tannir, Ashish M. Kamat, Donna E. Hansel, Charles C. Guo, Matthew T. Campbell, Omar Alhalabi

    Published 2025-01-01
    “…Histopathologic review was conducted by independent pathologists. Relapse event was the time‐to‐event outcome, and relapse probabilities were estimated using a competing risk method with cumulative incidence functions (CIFs). …”
    Get full text
    Article
  13. 173
  14. 174
  15. 175
  16. 176

    Comparative Analysis of ChatGPT and Human Expertise in Diagnosing Primary Liver Carcinoma: A Focus on Gross Morphology by Prakasit Sa-ngiamwibool, Thiyaphat Laohawetwanit

    Published 2025-02-01
    “…., with and without a scoring system), pathology residents, and pathologist assistants. The diagnostic accuracy and consistency of each participant group were evaluated. …”
    Get full text
    Article
  17. 177

    How Could Static Telepathology Improve Diagnosis in Neuropathology? by Myriam Remmelinck, M. Beatriz S. Lopes, Nathalie Nagy, Sandrine Rorive, Katja Rombaut, Christine Decaestecker, Robert Kiss, Isabelle Salmon

    Published 2000-01-01
    “…Using static telepathology the pathologist could be limited in diagnosis by problems in fields selection.…”
    Get full text
    Article
  18. 178
  19. 179

    Current Concepts in the Biopsy of Musculoskeletal Tumors by Costantino Errani, Francesco Traina, Fabrizio Perna, Carlotta Calamelli, Cesare Faldini

    Published 2013-01-01
    “…The choice of biopsy depends on the size, the location of the lesion, and the experience of the pathologist.…”
    Get full text
    Article
  20. 180

    Steatocystoma Multiplex: “Keep me in your Differentials” by Sudha Sharma, V. Anish Chandran, Praveen Kumar Shukla, Ajay Kumar

    Published 2024-05-01
    “…Histopathologic features are characteristic and should be known to the pathologist, to differentiate from other common causes of skin nodules. …”
    Get full text
    Article